m
Recent Posts
Connect with:
Wednesday / October 27.
HomeminewsSilmo d’Or for Transitions XTRActive Polarized

Silmo d’Or for Transitions XTRActive Polarized

A prestigious 2021 ‘Silmo d’Or’ has been awarded to Transitions XTRActive Polarized lenses – the latest breakthrough innovation to come from EssilorLuxottica.

The photochromic lenses combine the features of the XTRActive range, which include sharper vision, a larger view and vivid colours.

Among other EssilorLuxottica innovations showcased at the international tradefair were Ray-Ban Stories, the next generation of smart glasses. Highly anticipated, Ray-Ban Stories are the first product resulting from the company’s collaboration with Facebook, confirming its plan to expand availability to new countries, including France, by Q1 2022.

In a joint statement, Chrystel Barranger, President Europe at Essilor and President Transitions Optical, and Massimiliano Mutinelli, President Wholesale EMEA and APAC at Luxottica said: “We are proud to showcase the innovation capabilities that EssilorLuxottica can bring to the industry, with ground-breaking products such as Ray-Ban Stories, along with cutting-edge vision correction solutions and equipment that help ECPs power their practices.

“We are honoured to receive the ‘Silmo d’Or’ for the Transitions XTRActive Polarized lenses that address the need for extra darkness and polarization for wearers who are frequently exposed to bright light and reflective glare. All these innovations are a testament to our constant effort to push the boundaries of what’s possible to help people see more, be more and live life to its fullest.

“We would like to thank all our teams that have contributed to making this first Silmo participation under the EssilorLuxottica banner a success.”

DECLARATION

DISCLAIMER : THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.